|
2012
|
Invention
|
Activation of cellular assault processes in the treatment of glioblastoma multiforme. Polypeptide... |
|
2011
|
Invention
|
Egfr-based peptides. Observations regarding the role of MUC1 in promoting the nuclear accumulatio... |
|
2010
|
Invention
|
Modified chalcone compounds as antimitotic agents. Antimitotic agents comprising a modified chalc... |
|
2009
|
Invention
|
Use of therapeutic peptides for the treatment and prevention of cancer. MUC1 (DF3, CD227, episial... |
|
2008
|
Invention
|
Anticancer agents based on regulation of protein prenylation. Oncoproteins such as Ras and RhoB a... |
|
2007
|
Invention
|
Conjugated nitro alkene anticancer agents based on isoprenoid metabolism. Conjugated nitro alkene... |
|
2005
|
Invention
|
Anticancer agents based on prevention of protein prenylation. Prenylating enzymes are involved in... |
|
2002
|
Invention
|
Disulfone reagents and methods of preparing and using same. The present invention provides novel ... |
